INS and Insulin resistance: The decrease in the quantity and quality of skeletal muscle during the course of T2DM development significantly elevates insulin resistance of the whole body (Abdul-Ghani & DeFronzo, 2010), resulting in an increased TDD requirement in T2DM patients receiving insulin treatment.